Uterine leiomyoma is the most common gynecologic neoplasm and the major cause of hysterectomy in reproductive age women. Additionally, these tumors negatively impact reproductive function in women by contributing to infertility and complications of pregnancy. Little is known about the etiology of leiomyoma or the potential impact of environmental agents on the course of this disease. The goal of our research is to understand the etiology of uterine leiomyoma at the molecular level and to elucidate the molecular mechanisms by which exposure to endocrine disruptors may impact the development of these tumors.
In Specific Aim 1, we will determine if loss of Tsc-2 tumor suppressor gene/tuberin function and subsequent overexpression of HMGI-C is an alternative pathway for development of leiomyoma.
In Specific Aim 2, we will test the hypothesis that loss of tuberin is directly responsible for overexpression of HMGI-C and results in modulation of hormone responsiveness in tuberin deficient cells. Finally in Specific Aim 3, we will determine if the prepubertal period is a window of susceptibility for exposure to environmental xenoestrogens and determine at the molecular level whether this exposure impacts the expression of genes that may contribute to the development of leiomyoma. These experiments will yield new insights into the molecular mechanisms responsible for the altered responsiveness of uterine leiomyomas to endogenous and exogenous hormones and increase our understanding of the potential mechanisms by which exposure to endocrine disruptors could contribute to the development of this disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
3R01ES008263-06S1
Application #
6799008
Study Section
Reproductive Endocrinology Study Section (REN)
Program Officer
Heindel, Jerrold
Project Start
1996-08-01
Project End
2007-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
6
Fiscal Year
2003
Total Cost
$64,710
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Organized Research Units
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Park, In Young; Powell, Reid T; Tripathi, Durga Nand et al. (2016) Dual Chromatin and Cytoskeletal Remodeling by SETD2. Cell 166:950-962
Treviño, Lindsey S; Wang, Quan; Walker, Cheryl L (2015) Phosphorylation of epigenetic ""readers, writers and erasers"": Implications for developmental reprogramming and the epigenetic basis for health and disease. Prog Biophys Mol Biol 118:8-13
Treviño, Lindsey S; Wang, Quan; Walker, Cheryl L (2015) Hypothesis: Activation of rapid signaling by environmental estrogens and epigenetic reprogramming in breast cancer. Reprod Toxicol 54:136-40
Wong, Rebecca Lee Yean; Walker, Cheryl Lyn (2013) Molecular pathways: environmental estrogens activate nongenomic signaling to developmentally reprogram the epigenome. Clin Cancer Res 19:3732-7
Greathouse, K Leigh; Bredfeldt, Tiffany; Everitt, Jeffrey I et al. (2012) Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis. Mol Cancer Res 10:546-57
Walker, Cheryl Lyn; Ho, Shuk-mei (2012) Developmental reprogramming of cancer susceptibility. Nat Rev Cancer 12:479-86
Walker, Cheryl Lyn (2011) Epigenomic reprogramming of the developing reproductive tract and disease susceptibility in adulthood. Birth Defects Res A Clin Mol Teratol 91:666-71
Short, John D; Dere, Ruhee; Houston, Kevin D et al. (2010) AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stability. Mol Carcinog 49:429-39
McCampbell, Adrienne S; Broaddus, Russell R; Walker, Cheryl L (2010) Loss of inhibitory insulin receptor substrate-1 phosphorylation: An early event in endometrial hyperplasia and progression to carcinoma. Cell Cycle 9:2698-9
McCampbell, Adrienne S; Harris, Heather A; Crabtree, Judy S et al. (2010) Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma. Cancer Prev Res (Phila) 3:290-300

Showing the most recent 10 out of 36 publications